Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim)

British Journal of Haematology

Volumn 93, Issue 4, 1996, Pages 863-868

  Johnson, R J ^a   Owen, R G ^a   Child, J A ^a   Morgan, G J ^a   Barnard, D L ^b   Dickinson, H ^a   Ricketts, S ^b   Rawstron, A ^a   Evans, P ^a   Woodhead, V ^a   Major, K ^a   Robinson, F ^a   Smith, G M ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

chronic myeloid leukaemia; hydroxyurea; mobilization; peripheral blood stem cells; Philadelphia negative

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA;

ADULT; ARTICLE; BLOOD CELL; CELL ISOLATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MONONUCLEAR CELL; MUCOSA INFLAMMATION; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 8944250673     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1717.x     Document Type: Article

References (26)

1. Allan, N.C., Richards, S.M. & Shepherd, P.C. (1995) U.K. Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia. Lancet, 345, 1392-1397.
2. Anastasi, J., Feng, J., Le Beau, M.M., Larson, R.A., Rowley, J.D. & Vardiman, J.W. (1995) The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia. Leukemia, 9, 628-633.
3. Barnett, M.J., Eaves, C.J., Phillips, G.L., Hogge, D.E., Klingemann, H.G., Lansdorp, P.M., Nantel, S.H., Reece, D.E., Shepherd, J.D. & Sutherland, H.J. (1993) Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver study. Stem Cells, 11, (Suppl. 3), 64-66.
4. Bergamaschi, G., Podesta, M., Frassoni, F., Rosti, V., Carella, A.M., Saglio, G. & Cazzola, M. (1994) Restoration of normal polyclonal haemopoiesis in patients with chronic myeloid leukaemia autografted with Ph-negative peripheral stem cells. British Journal of Haematology, 87, 867-870.
5. Carella, A.M., Frassoni, F. & Negrin, R.S. (1995a) Antografting in chronic myelogenous leukemia: new questions. Leukemia, 9, 365-369.
6. - cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia. Journal of Hematotherapy, 3, 199-202.
7. Carella, A.M., Frassoni, F., Pollicardo, N., Pungolino, E., Ferrero, R., Vasallo, F., Soracco, M., Giordano, D., Figari, O. & Benvenuto, F. (1995b) Philadelphia-chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after myelosuppressive chemotherapy in Philadelphia-chromosome-positive acute lymphoblastic leukaemia. British Journal of Haematology, 89, 535-838.
8. Carella, A.M., Frassoni, F., Pollicardo, N., Pungolino, E., Podesta, M., Giordano, D., Ferrero, R., Soracco, M., Benvenuto, F. & Figari, O. (1994b) Ph-negative blood progenitor cells (BPCs) can be recruited after chemotherapy and G-CSF during early hemopoietic recovery in patients at diagnosis of CML or pretreated only with hydroxyurea. Bone Marrow Transplantation, 14, (Suppl. 3), S34-S37.
9. Carella, A.M., Podesta, M., Frassoni, F., Pungolino, E., Pollicardo, N., Raffo, M.R., Ferrero, R., Benvenuto, F., Figari, O., Giordano, D. Lecari, G., Carlier, P., Valbonesi, M., Vitare, V., Parodi, M., Gallamini, A., Saglio, G. & Marmont, A.M. (1993a) Selective overshoot of Ph-negative blood hemopoietic cells after intensive idarubicin-containing regimen and their repopulating capacity after reinfusion. Stem Cells, 11, (Suppl.), 67-72.
10. Carella, A.M., Pollicardo, N., Pungolino, E., Raffo, M.R., Podesta, M., Ferrero, R., Pierluigi, D., Nati, S., Naibo, K., Congiu, A., Spriano, M., Vimercati, R., Figari, O., Rosso, C., Saglio, C., Sessarego, M., Lercari, G., Valbonesi, M., Carlier, P., Vitare, V., Corvo, P. & Parodi, M. (1993b) Mobilization of cytogenetically 'normal' blood progenitors cells by intensive conventional chemotherapy for chronic myeloid and acute lymphoblastic leukemia. Leukemia and Lymphoma, 9, 477-483.
11. Carella, A.M., Pollicardo, N., Raffo, M.R., Podesta, M., Carlier, P., Valbonesi, M., Lercari, G., Vitale, V. & Gallamini, A. (1992) Intensive conventional chemotherapy can lead to a precocious overshoot of cytogenetically normal blood stem cells (BSC) in chronic myeloid leukemia and acute lymphoblastic leukemia. Leukemia, 6, (Suppl.), 120-123.
12. Chalmers, E.A., Franklin, I.M., Kelsey, S., Clark, R., Sproul, A.M., Goldstone, A.H., Hepplestone, A., Watson, W., Sharp, S. & Tansey, P. (1994) Mobilisation of Ph - ve peripheral blood stem cells in CML with idarubicin and cytarabine. Bone Marrow Transplantation, 14, (Suppl. 3), S38-S41.
13. Daley, G.Q. & Goldman, J.M. (1993) Autologous transplant for CML revisited. Experimental Hematology, 21, 734-737.
14. Giralt, S., Kantarjian, H. & Talpaz, M. (1995) The natural history of chronic myelogenous leukemia in the interferon era. Seminars in Hematology, 32, 152-158.
15. Goldman, J.M. (1994) Autografting for CML - where does it lit in to the overall treatment strategy?. Bone Marrow Transplantation, 14, (Suppl. 3), S74-S77.
16. Hehlmann, R., Heimpel, H., Kolb, H.J., Heinze, B., Hochhaus, A., Griesshammer, M., Pralle, H., Queisser, W.P., Essers, U., Falge, C. Bergmann, L., Queisser, U., Meyer, P., Schmitz, N., Wickramanayake, P.D., Walther, P., Westerhausen, M., Kleeberg, V.R., Heilein, A., Heiss, F., Zimmermann, R., Meuret, G., Tichelli, A., Berdel, W.E., Tigges, F.J., Eimermacher, H., Schmid, L., Zankovich, R., Thiere, J., Loftler, H., Wussow, P.V., Buhr, T., Georgii, A., Hossfield, D.K., Ansari, H., Hasford, J., and the German CML study group. (1993) The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1. Leukemia and Lymphoma, 11, (Suppl.), 159-168.
17. Hehlmann, R., Kister, P., Willer, A., Simon, M., Schenk, M., Seifarth, W., Papakonstantinou, G., Saussele, S., Kolb, H.J., Ansari, H., Leib-Mosch, C., and the German CML study group. (1994) Therapeutic progress and comparative aspects in chronic myelogenous leukemia (CML): interferon alpha vs. hydroxyurea vs. busulfan and expression of MMTV-related endogenous retroviral sequences in CML. The German CML Study Group. Leukemia, 8, (Suppl.), 127-132.
18. Jonte, F., Barez, A., Soto, I., Rayon, C., Carrera D., Coma, A., Perez, L., Landeral, J. & Arribas, M. (1992) Features of chronic myeloid leukaemia at diagnosis: study of a series of 134 cases. Sangre, 34, 345-350.
19. Kolitz, J.E., Kempin, S.J., Schluger, A., Wong, G.Y., Berman, E., Jhanwar, S., Arlin, Z.A., Gee, T. & Clarkson, B.D. (1992) A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia. Seminars in Oncology, 19, (Suppl.), 27-33.
20. Kuss, B.J., Sage, R.E., Shepherd, K.M., Hardingham, J. & Nicola, M. (1993) High dose hydroxyurea in collection of Philadelphia chromosome-negative stem cells in chronic myeloid leukemia. Leukemia and Lymphoma, 10, 73-78.
21. McGlave, P.B., De Fabritiis, P., Deisseroth, A., Goldman, J., Barnett, M., Reiffers, J., Simonsson, B., Carella, A. & Aeppli, D. (1994) Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. Lancet, 343, 1486-1488.
22. Mughal, T., Hoyle, C. & Goldman, J.M. (1993) Autografting for patients with chronic myeloid leukemia: the Hammersmith experience. Stem Cells, 11, (Suppl.), 20-22.
23. Nichols, G.L. (1995) Antisense oligodeoxynucleotides as therapeutic agents for chronic myelogenous leukaemia. Antisense Research and Development, 5, 67-69.
24. O'Brien, S.G. & Goldman, J.M. (1994) Autografting in chronic myeloid leukaemia. Blood Reviews, 8, 63-69.
25. O'Brien, S.G. & Goldman, J.M. (1995) Current approaches to hematopoietic stem-cell purging in chronic myeloid leukemia. Journal of Clinical Oncology, 13, 541-546.
26. The Italian Cooperative Study Group on Chronic Myeloid Leukemia (1994) Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New England Journal of Medicine, 330, 820-825.